Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Spinal muscular atrophy : Time for newborn screening?]

Der Nervenarzt - 1 Dec 2017

Vill K, Blaschek A, Schara U, Kölbel H, Hohenfellner K, Harms E, Olgemöller B, Walter Maggie C, Müller-Felber W

Abstract excerpt

The most common neurodegenerative disease in childhood is spinal muscular atrophy (SMA). The severe infantile type 1 (Werdnig-Hoffman disease) makes 60% of SMA in total. These children usually die within 18 months without ventilation. New therapeutic approaches have led from the theoretical concept to randomized controlled clinical trials in patients. For the first time, a pharmacological treatment of SMA has...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Early Diagnosis
Share to Gene Deletion
Share to Genetic Carrier Screening

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neonatal Screening

Share to Randomized Controlled Trials as Topic

Share to Spinal Muscular Atrophies of Childhood

Share to Survival of Motor Neuron 1 Protein

Share to Survival of Motor Neuron 2 Protein

Source

Identifiers

PMID: 29101527
DOI: 10.1007/s00115-017-0447-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Spinal muscular atrophy : Time for newborn screening?]PMID 29101527Read ↗

Spinal muscular atrophy: a time for screeningSemantic proximity Read ↗

Advances in Newborn Screening and Presymptomatic Diagnosis of Spinal Muscular AtrophySemantic proximity Read ↗

Newborn Screening for SMA - Results After Two Years of a Large Pilot Project Semantic proximity Read ↗

[Clinical practice guidelines for spinal muscular atrophy].Semantic proximity Read ↗

[Gene-based treatment in spinal muscular atrophy].Semantic proximity Read ↗

Three years pilot of spinal muscular atrophy newborn screening turned into official program in Southern Belgium.Semantic proximity Read ↗

Experience of a 2-year spinal muscular atrophy NBS pilot study in Italy: towards specific guidelines and standard operating procedures for the molecular diagnosis.Semantic proximity Read ↗

Spinal muscular atrophy: newborn and carrier screening.Semantic proximity Read ↗

Prenatal aspects in spinal muscular atrophy: From early detection to early presymptomatic intervention.Semantic proximity Read ↗

[SMA: from gene discovery to gene therapy].Semantic proximity Read ↗

In utero therapy for spinal muscular atrophy: closer to clinical translationSemantic proximity Read ↗

[Infantile spinal atrophy: our experience in the last 25 years].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.